People with Down syndrome are no strangers to specialty care. They regularly see a host of physicians— geneticists, cardiologists, endocrinologists, gastroenterologists, and others—to keep their vital internal organs healthy. But their largest external organ has not historically received the same attention, either in medical practice or in research.
“Dr. Rork’s work establishes a compassionate standard of care that serves as a model for other dermatologists around the country,” says Shane Chapman, MD, MBA, chair of the Department of Dermatology at DHMC and Geisel.
Whole-Body Care
People with Down syndrome, or trisomy 21, have three copies of chromosome 21 instead of the standard two. This affects the development of both brain and body, and leads to a suite of chronic or recurring health conditions. People with Down syndrome often have more difficulty fighting infections and a greater occurrence of autoimmune disorders, such as autoimmune thyroid disease and celiac disease, among other health challenges.

They are also at higher risk for hidradenitis suppurativa (HS), alopecia areata, psoriasis, and other skin diseases. “These skin conditions can be really challenging to treat,” Rork says, especially when patients have coexisting medical conditions.
Take HS, for example. “One of the drugs used to treat HS can work really well, but it can lower the patient’s blood pressure, and people with Down syndrome are historically known to have lower blood pressures,” she explains.
And it doesn’t stop there: “People with Down syndrome are more prone to respiratory conditions, and some of the medications for HS turn down the immune system, making patients potentially more vulnerable to respiratory infections,” Rork adds. “These patients are also more prone to specific types of blood cancers, and some HS medications can increase the risk of blood cancers. We need to be constantly asking: ‘What are these risks like for someone with Down syndrome?’”
These co-occurring challenges are also the subject of Rork’s research. Consideration of heart health in these patients is the basis of her new study, “Down Syndrome and Psoriasis: An Investigation of Cardiometabolic Risk.”